Talkspace, Inc.

NASDAQ•TALK

CEO: Dr. Jon R. Cohen M.D.

Sector: Healthcare

Industry: Medical - Care Facilities

Listing Date: 2020-07-30

Talkspace, Inc. operates as a virtual behavioral healthcare company in the United States. The company offers psychotherapy and psychiatry services through its platform to individuals, enterprises, and health plans and employee assistance programs. It provides text, audio, and video-based psychotherapy from licensed therapists. The company offers Talkspace Employee Assistance Program (EAP) and Talkspace Behavioral Health plan (BH) that provides online therapy to members through BH and EAP offerings; and Talkspace for Business for members to access its platform services on a benefit plan paid by the enterprise. It serves its platform through third-party platforms or marketplace, such as Apple App Store and Google Play App Store. Talkspace, Inc. was founded in 2012 and is headquartered in New York, New York.

Contact Information

622 Third Avenue, New York, NY, 10017, United States

212-284-7206

www.talkspace.com

Market Cap

$863.78M

P/E (TTM)

111.7

48.2

Dividend Yield

52W High

$5.20

52W Low

$2.22

52W Range

99%

Rank51Top 71.3%

3.0

F-Score

Modified Piotroski Analysis

Based on 6-year fundamentals

Weak • 3 / 9 points

Scoring Range (0-9)

8-9: Excellent Value

6-7: Strong Fundamentals

4-5: Average Quality

0-3: Weak Performance

Data Period: 2020-2025

Financial Dashboard

Q4 2025 Data

Revenue

$63.00M+0.00%

4-Quarter Trend

EPS

$0.03+0.00%

4-Quarter Trend

FCF

$2.08M+0.00%

4-Quarter Trend

2025 Annual Earnings Highlights

Key Highlights

Revenue Growth Strong Payor Shift Total revenue reached $228.9M USD, up 22.0%, driven by Payor revenue increasing 37.9% year-over-year.

Net Income Substantial Improvement Net income surged to $7.793M USD in 2025 from $1.148M USD in 2024, reflecting 578.8% growth.

Strategic Acquisition Completed Acquired Wisdo Health platform on October 1, 2025, enhancing social health capabilities and peer support offerings.

Strong Cash Position Maintained Maintained $37.4M USD in cash and equivalents as of December 31, 2025, with no outstanding debt reported.

Risk Factors

Merger Uncertainty Business Disruption Pending UHS merger may disrupt relationships, divert management attention, and cause negative publicity impacting operations.

Competitive Industry Pressures Intense competition from specialized providers and large tech firms may cause continued pricing pressures and market share loss.

Regulatory Compliance Complexity Evolving federal and state healthcare laws, including corporate practice of medicine rules, pose ongoing compliance risks.

Consumer Segment Revenue Decline Consumer revenue fell 29.5% due to strategic focus shift away from consumer marketing efforts toward Payor members.

Outlook

Merger Expected Closing Q3 2026 Merger with UHS is expected to close in the third quarter of 2026, resulting in delisting from NASDAQ.

AI LLM Integration Advancement Utilizing proprietary Sentia AI LLM to extend clinician reach, enhance engagement, and reduce burnout across platform.

Continued Payor Focus Strategy Strategy emphasizes expanding Payor utilization and health plan customer base while optimizing Consumer marketing spend.

Intellectual Property Protection Relying on patents, trademarks, and trade secrets to protect proprietary technology, despite ongoing challenges risk.

Peer Comparison

Revenue (TTM)

CYH

$12.49B

-1.2%

AGL

$5.93B

-2.1%

EHAB

$1.06B

+2.4%

Gross Margin (Latest Quarter)

RIGL

91.5%

+7.7pp

KALV

90.4%

+0.0pp

CLPT

61.5%

+3.5pp

Key Metrics

Symbol	Market Cap	P/E (TTM)	ROE (TTM)	Debt to Assets
AVNS	$1.15B	-16.8	-8.6%	12.0%
INNV	$1.14B	-275.7	-1.7%	22.2%
KALV	$1.00B	-5.9	-444.4%	84.7%

Long-Term Trends

Last 4 Quarters

Revenue

Net Income

Operating Cash Flow

4Q Revenue CAGR

6.5%

Steady Growth

4Q Net Income CAGR

146.5%

Profitability Improved

Cash Flow Stability

50%

Cash Flow Needs Attention

Deep Research

Next earnings:May 4, 2026

EPS:-

Revenue:-

Financials

Earnings Calls

Reports

News

Income Statement

Balance Sheet

Cash Flow Statement

Ratios

% Chg.

Income Statement	LTM

No Data